FIELD: medical engineering. SUBSTANCE: device has one or several amplifiers possessing penetrating ability and drug to be selected from thiagabine, its pharmaceutically acceptable salts, pharmaceutically acceptable C1-6-alkyl polyesters or ionic pairs of thiagabine and salicylic or oleic acid. Penetrating amplifier is selected from a group consisting of saturated and unsaturated fatty acids and their esters in propylene glycol, bisabolol in ethanol/water. EFFECT: lower daily doses of thiagabine; avoided adverse side effects. 9 cl, 1 tbl
| Title |
Year |
Author |
Number |
| R(-)-N-[4,4-DI-(3-METHYLTHIENE-2-YL)-BUT-3-ENYL]-NIPECOTIC ACID HYDROCHLORIDE ANHYDROUS CRYSTALLINE FORM, METHOD OF ITS PREPARING, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT |
1997 |
- Arntt Preben
- Petersen Khenning Berge
- Chang Vinsent Kh.
- Allen Kimberli Ehnn
- Chejn Majkl Kh.
|
RU2177478C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING THIAGABIN HYDROCHLORIDE |
1996 |
- Svensson Jergen Rjukhl'
- Njugor Lars
- Andersen Tina Mejnerts
- Vejbel' Khelle
- Jort Tjuge Borup
|
RU2173996C2 |
| DERIVATIVES OF [1,2,4]-TRIAZOLO-[4,3-A]-QUINOXALINONE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF AMPA- -RECEPTORS |
1995 |
- Nel'Sen Flemming Ehl'Melund
|
RU2149162C1 |
| CRYSTALLINE (-)-3R,4R-TRANS-7-METHOXY-2,2- DIMETHYL-3-PHENYL-4-4-[2- (PYRROLIDIN-1- YL)ETHOXY]PHENYLCHROMAN HYDROFUMARATE, METHOD OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF DECREASE OR PROPHYLAXIS OF BONE RESORPTION |
1997 |
- Treppendakhl' Svenn
- Ensen Klaus Snaj
- Makgro Skott Eh.
|
RU2182149C2 |
| INJECTION NEEDLE |
1997 |
|
RU2180861C2 |
| "CLOVER" PEPTIDE DIMER |
1995 |
- Tim Lars
- Vel'Dike Khelle Fabrisius
- Nil'Sen Per Franklin
|
RU2162857C2 |
| MODIFIED FACTOR VII |
1995 |
- Berkner Kehtlin L.
- Petersen Lars Khristian
- Khart Charlz Eh.
- Khedner Ulla
- Bregengor Klaus
|
RU2214833C2 |
| ZINC-FREE INSULIN CRYSTAL FOR APPLICATION IN PULMONARY COMPOSITIONS |
1998 |
|
RU2198181C2 |
| N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS AND PHARMACEUTICAL COMPOSITION |
1997 |
- Andersen Khenrik Sune
- Jergensen Tine Krog
- Khol'Veg Rol'F
- Andersen Knud Ehrik
- Polivka Zdenek
|
RU2186769C2 |
| 2-AMINO-N-{(1R)-2-[(3R)-3-BENZYL-3-(N,N',N'-TRIMETHYLHYDRAZINOCARBONYL)PIPERIDINE-1-YL]-1-(1H-INDOL-3-YLMETHYL)-2-OXOETHYL}-2-METHYLPROPIONAMIDE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR STIMULATION OF GROWTH HORMONE RELEASE FROM MAMMAL HYPOPHYSIS |
2000 |
|
RU2272034C2 |
